Professionals from the Urology Service and the Pathological Anatomy Service

Parc Taulí incorporates a non-invasive technique to detect relapses in patients undergoing bladder cancer

Parc Taulí incorporates a non-invasive technique to detect relapses in patients undergoing bladder cancer 1024 608 Parc Taulí current affairs

Parc Taulí has ​​incorporated the so-called urine test EpiCheck Bladder, to monitor patients undergoing high-grade bladder cancer, one of the most prevalent pathologies of urological tumors and with a high rate of relapse. The aim is to improve patient safety and comfort, while avoiding possible admissions and / or complications.

Patients diagnosed with bladder cancer should follow an ongoing surveillance protocol based on the risk of recurrence or progression of their disease. This protocol is usually performed by cystoscopy, an invasive procedure associated with certain complications and discomfort (bleeding, infections…) that is performed through the urethra, by inserting a medical device similar to a probe with a built-in camera.

At Parc Taulí, nearly 200 surgeries are performed annually on patients diagnosed with high-grade superficial bladder cancer, who could benefit from this technique, and an average of 300 patients are monitored. The test is performed on the instructions of professionals from the Urology Service in collaboration with professionals from the Pathological Anatomy Service.

El EpiCheck Bladder is a molecular study of advanced technology and high reliability, which is done on a urine sample. It is endorsed by the European Association of Urology in its latest clinical guidelines (2022). It can distinguish healthy cells from cancer cells and could prevent the invasive procedure of follow-up cystoscopies, thus ensuring an improvement in patient safety and comfort.

75% of bladder tumors are of the high-grade superficial type that are characterized by recurrence of recurrences and require surgical treatment. To monitor these patients, treatment (chemotherapy and / or immunotherapy) is performed together with two annual cystoscopies during the first two years and one cystoscopy per year from the third year of chronic disease control.

Press release in pdf

1 comment
  • José del Pozo Muñoz

    Good morning, I am very interested to know what steps I need to take, where and how so that they can perform the new non-invasive test for patients who have had bladder cancer. In my case I have been operated on twice, none in Parc Taulí.
    How should I contact Urology?
    Can they take care of me even if it's not my usual hospital?
    I look forward to your response. Thanks and regards.

Leave a comment

Your email address will not be published.

Privacy preferences

When you visit our website, your browser may store information about specific services, usually in the form of cookies. Here you can change your privacy preferences. Please note that blocking certain types of cookies may affect your experience on our website and the services we offer.

Enable / disable Google Analytics tracking code
Enable / disable Google Fonts
Turn Google Maps on / off
Enable / disable embedded videos
This website uses cookies, mainly from third party services. You can edit your privacy preferences and / or accept the use of cookies.